WW (Weight Watchers) — The Brief, the Feedback, and the Collapse of a Creative Relationship

In September 2018, Weight Watchers became WW. The rebrand was announced at a launch event in New York with CEO Mindy Grossman on stage and Oprah Winfrey providing video endorsement. The new brand positioning was "Wellness That Works." The promise, repeated across investor communications and press releases, was that the sixty-year-old diet brand was becoming something larger and more modern — a holistic wellness platform for a new generation of health-conscious women. Five and a half years later, in March 2024, Oprah Winfrey announced that she was leaving the WW board, citing a conflict of interest created by her use of GLP-1 weight-loss medications. By that point, WW's subscriber count had collapsed, its revenue had fallen by nearly a third, its stock price had fallen by roughly 95 per cent from its 2018 peak, and the company was trading closer to bankruptcy than to recovery. The story of what went wrong at WW is not simply a story of bad creative work, and it is not simply a story of market disruption from new weight-loss pharmaceuticals. It is a story of what happens when the organisational fundamentals of a marketing function — the brief, the feedback structure, and the intervention rights — are weak, and when even a well-regarded agency, a famous celebrity endorsement, and a generous budget cannot compensate for structural failures inside the client organisation.

The Situation

Weight Watchers was founded in 1963 by Jean Nidetch in Queens, New York, as a weekly group meeting for people who wanted to lose weight together. The business had operated for decades on a model that combined dietary guidance, group accountability meetings, and a branded points system that members used to track food intake. By the 2010s, the company had evolved its offering to include digital tracking apps, but the underlying proposition — a supportive community-based approach to weight loss, with a simple system for counting food — had remained fundamentally stable. The brand was strongly associated with its decades of member success stories, its "before and after" marketing, and its celebrity endorsements, most prominently Oprah Winfrey, who had joined the company as both an investor and spokesperson in 2015 and who became a visible public advocate for the programme.

By 2017, Weight Watchers was facing a recognisable strategic problem. The weight-loss category was changing. Younger consumers, particularly women in their twenties and thirties, were expressing growing resistance to diet culture and embracing a broader conception of health that included mental wellness, intuitive eating, body neutrality, and rejection of conventional weight-loss messaging. The Instagram generation had produced a large and commercially significant audience that was hostile to the frame Weight Watchers had used for fifty years. Meanwhile, the brand's traditional customer base — older women who had been members of Weight Watchers for decades — remained loyal but was not growing. The commercial question was how to reposition the brand for a new audience without alienating the existing one.

Mindy Grossman was hired as CEO in July 2017 specifically to lead this transformation. Grossman came from the Home Shopping Network, where she had successfully modernised a brand that many observers had considered commercially stranded. Her brief from the Weight Watchers board, supported vocally by Oprah Winfrey, was to move the company from diet to wellness — to reposition the brand for the post-Instagram generation while retaining enough of its heritage to keep existing members engaged. The stock market responded enthusiastically to her appointment. Weight Watchers stock rose from roughly USD 40 in July 2017 to more than USD 100 by mid-2018, on the strength of the new strategy narrative and strong short-term subscriber numbers that accompanied Grossman's first year.

The agency hired to lead the rebrand creative was MullenLowe, which was given the brief to reposition the brand as "Wellness That Works." The new logo — two letters, WW — was designed to signal a break from the diet-focused Weight Watchers name while preserving some visual continuity. The launch campaign framed the repositioning around holistic wellness: mental health, fitness, sleep, mindfulness, nutrition, and community support. The brand promise was that the programme was about more than losing weight. It was about living a healthier life in a more complete sense.

This was, on paper, a defensible strategic response to a real market shift. The problem was that the strategic response was being translated into creative work through an organisational process that was not equipped to deliver clarity, and the creative work that emerged reflected the confusion of the process rather than the clarity of the underlying strategy.

The Decision

The brief to MullenLowe, reconstructed from coverage in Ad Age, Campaign, and subsequent reporting by former insiders, was ambitious but poorly defined. The central strategic question — who is the target customer, and what does WW have to offer her that her alternatives do not — was not answered clearly. The brief described an expanded audience that included "women seeking holistic wellness," but it did not specify whether these women were existing diet-conscious consumers seeking a broader framework, or wellness-focused consumers seeking a structured programme, or both. It described a positioning shift from diet to wellness but did not specify what to do with the weight-loss element of the existing programme, which remained core to the commercial proposition and to the reasons existing members were paying their subscriptions. It described a modernisation of tone and visual identity but did not specify what tonal registers to preserve from the old brand versus abandon. The brief, in effect, asked the agency to solve a problem that the client had not yet solved for itself.

The client-side approval structure compounded the problem. Several people involved in the process have described, in subsequent press accounts, an approval chain that included Grossman herself, her marketing leadership team, the WW board, and — informally but influentially — Oprah Winfrey and her personal team. Each of these stakeholders had legitimate interest in the creative output. Each had different instincts about what the brand should feel like. None had clean, decisive authority to make the final calls. The result was a creative development process in which every round of work produced feedback from multiple directions, often contradicting each other, with no named decision-maker empowered to resolve the contradictions. When Oprah's team had a view on the tone of a piece of work, that view carried disproportionate weight because of the political sensitivity of her involvement. When the board had a view on the commercial viability of a proposed direction, that view carried weight because of financial exposure. When Grossman had a view, she was the CEO, but she was navigating the other stakeholders as well as the creative decision itself.

The work that emerged from this process was tonally inconsistent in ways that were visible to consumers. Some of the new WW advertising in 2018 and 2019 felt aspirational and modern — photography of women practising yoga, preparing colourful meals, spending time with friends in lifestyle settings. Other work felt like a lightly refreshed version of the old Weight Watchers messaging, with the same focus on weight loss and member testimonials that had defined the brand for decades. The brand on Instagram and on television looked like two different brands. The new tonal direction did not displace the old one; it sat alongside it awkwardly, and the combination confused both audiences. Existing Weight Watchers members, who had joined the programme to lose weight and who were proud of their progress, felt alienated by the suggestion that their goal was no longer central to the brand. Younger wellness-focused women, who might have been interested in a genuinely modern health platform, saw through the repositioning and recognised the underlying diet programme. Neither audience was won. Both were confused.

The internal dynamics of the creative process reportedly became more difficult over 2019 and 2020. Agency-side accounts, where they have surfaced through industry reporting, describe a relationship in which pushback on the strategic coherence of the brief was difficult to sustain because the client's approval structure was too diffuse to engage with. When MullenLowe tried to raise concerns about the tonal contradictions between the old and new brand messaging, those concerns would be acknowledged by some stakeholders and dismissed by others. There was no single person on the client side with both the authority to make hard strategic calls and the willingness to use that authority to impose coherence. The agency was asked to produce work that satisfied multiple stakeholders with incompatible expectations. It tried, but the output was necessarily incoherent, and the incoherence was visible in the market.

The business consequences of the creative failure compounded with other pressures. The subscriber decline began in early 2019, with the company reporting 4.1 million subscribers at the end of Q1 2019 compared with 4.6 million in the same quarter a year earlier. Revenue followed the subscriber line downward through 2019 and 2020. The stock price, which had peaked above USD 100 in mid-2018, fell below USD 30 by the end of 2019 and below USD 20 by mid-2020. The company took on additional debt to fund operations and sustain the marketing programme, accumulating more than USD 1.5 billion in debt obligations that would become increasingly difficult to service as revenue continued to decline.

COVID-19 made everything worse. The in-person meetings model that had been the heart of Weight Watchers' community offering was effectively suspended during the pandemic, and while the company had digital tools, the community element had been one of the brand's core differentiators. The shift to fully digital delivery exposed how much of the value proposition had depended on the physical meetings, and the brand's ability to communicate a clear reason to subscribe grew weaker rather than stronger.

By 2022, Mindy Grossman had left the company. She was replaced by Sima Sistani, a former Yahoo and Houseparty executive, who attempted another repositioning — this time toward behavioural health and chronic disease management — but the new direction struggled to gain traction in a brand that was by then associated with confusion rather than conviction. The board's confidence in the marketing strategy had collapsed, and the underlying commercial trajectory continued downward.

The final symbolic moment came in March 2024, when Oprah Winfrey announced that she was leaving the WW board. Her stated reason was a conflict of interest: she had begun using a GLP-1 weight-loss medication (the class of drugs including Ozempic, Wegovy, and Mounjaro, which had emerged during 2022-2023 as the most commercially disruptive development in the weight-loss category in a generation) and she no longer felt she could serve as a director of a company whose core programme was being directly challenged by the drugs she was personally using. The departure was accepted by the board. It was also, in a way that was almost unbearably pointed, a public acknowledgement that WW had never resolved the central contradiction in its own positioning. A brand that had been trying to become a wellness platform for six years lost its most prominent endorser because she had chosen pharmaceutical weight loss over the WW programme. The departure captured the failure of the entire repositioning exercise in a single news cycle.

The Data

Metric	2017 (pre-rebrand)	2018 (rebrand year)	2020	2022	2023
Total subscribers (m)	3.6	4.6	4.4	3.6	3.5
Revenue (USD m)	1,306	1,513	1,367	1,039	889
Operating income (USD m)	201	263	188	(282)	(112)
Stock price (approx, USD)	40	100 (peak)	22	7	4
Long-term debt (USD m)	1,533	1,515	1,446	1,434	1,475

The data tells a stark story. The rebrand year itself, 2018, looks successful in isolation: subscribers grew to 4.6 million, revenue grew to USD 1.5 billion, and the stock price reached its all-time high. The subsequent three years reversed almost all of the gains. By 2020, subscribers had fallen below the 2018 peak and continued falling. Revenue followed the same trajectory. Operating income turned sharply negative in 2022 and remained negative in 2023. The stock price loss was catastrophic, falling from approximately USD 100 to approximately USD 4 — a decline of more than 95 per cent.

The debt load is also worth noting. WW was carrying approximately USD 1.5 billion in long-term debt from the start of the period, which was sustainable when the company's revenue was in the USD 1.3-1.5 billion range with positive operating income. As revenue fell and operating income turned negative, the debt became a binding constraint on the company's strategic options. There was no financial room to wait out a difficult period. Every missed quarter made the underlying financial position worse.

The GLP-1 drug disruption deserves specific attention because it intersects with the marketing failure in a critical way. The GLP-1 class of weight-loss medications, which includes Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Mounjaro, emerged as commercially disruptive during 2022-2023. The drugs produce weight loss outcomes that are dramatically more effective than any dietary or behavioural programme has ever achieved. The clinical data showing 15-20 per cent body weight reductions over treatment periods of several months has made the drugs credible alternatives for the core WW customer — someone seeking meaningful weight loss — in ways that no previous pharmaceutical intervention had achieved. WW's response to this challenge, during 2023, was to acquire a telehealth provider, Sequence, that could prescribe GLP-1 drugs, and to offer these services as part of the WW platform. The acquisition was strategically sensible, but it came after years of weakening brand positioning, and the combined product offering was never clearly communicated to the market. The brand confusion that had begun with the rebrand in 2018 compounded with the GLP-1 disruption, and the result was that WW entered the GLP-1 era without the strategic clarity needed to defend its historical ground or to claim new territory.

The Marketing Organisation Lesson

F10-04's argument about the brief is that most marketing fails before it starts — that weak briefs produce weak work regardless of the quality of the agency, the budget, or the celebrity involvement. The WW case is the most complete contemporary illustration of that argument. The brief was not merely imperfect. It was incoherent. It tried to be about diet and wellness simultaneously. It tried to address existing members and new audiences simultaneously. It tried to preserve heritage and achieve modernisation simultaneously. Each of these was a legitimate concern, but the brief did not resolve the tensions between them. It passed the tensions through to the agency with the implicit expectation that creative work would somehow bridge them. Creative work cannot bridge strategic contradictions that are not resolved at the strategy level. An agency asked to serve two incompatible briefs simultaneously will produce work that serves neither.

F10-05's argument about evaluation and feedback is equally relevant. The WW client-side approval structure had no single named decision-maker with clean authority to make hard calls. Grossman was CEO, but she was navigating the board, the investors, the senior marketing team, and the political influence of Oprah Winfrey. When creative work came back from MullenLowe for review, the feedback went through multiple filters, each with different preferences, and the resolution of conflicts between filters was managed informally rather than decided by an empowered individual. In such a feedback structure, creative work tends toward the mean — the version that offends the fewest stakeholders wins, regardless of whether it is the sharpest or most effective version. Diffuse feedback produces mediocre creative. WW's feedback structure was more than diffuse; it was politically sensitive in ways that made honest creative conversation difficult. Agency recommendations that contradicted Oprah's team's preferences were hard to sustain. Agency recommendations that contradicted the board's commercial concerns were hard to sustain. The agency could recommend, but it could not effectively insist.

F10-06's argument about the agency as interventionist depends on the agency having earned standing within the client organisation and being structurally able to use that standing. At Nike, Wieden and Kennedy could refuse a Nike brief because the relationship was built on forty years of mutual trust and because the structural conditions — independent agency, retainer fees, long tenure, named decision-makers — made refusal viable. At WW, MullenLowe had no such structural platform. The relationship was newer, the approval structure was diffuse, the political sensitivities were high, and the fee model did not support the kind of sustained strategic engagement that an interventionist partnership requires. The agency could raise concerns, but it could not intervene decisively. The pushback capacity that would have been needed to say "this brief is incoherent, and we need to resolve it before producing work" was simply not available to MullenLowe within the structural terms of the relationship.

The deeper lesson is that a strong client-side marketing organisation is a precondition for strong creative work, regardless of the quality of the external agency. WW had a well-regarded agency, significant budget, and the most famous celebrity endorser in American media. What it did not have was a client-side structure capable of defining clear problems, delivering coherent feedback, and empowering interventionist conversations. Without those client-side capabilities, the external inputs — however capable — could not compensate for the internal failures. The brief, the feedback, and the intervention rights are not nice-to-haves. They are the organisational scaffolding that allows creative work to succeed.

The counter-factual question is worth asking: would a different agency have produced different results? It is tempting to argue that a more confrontational agency — one with the tenure and standing of Wieden and Kennedy at Nike — might have forced the WW client organisation to resolve its strategic contradictions before producing work. But the structural analysis suggests this is unlikely. An agency can only intervene when the client organisation has both the authority structure to receive the intervention and the willingness to act on it. At WW, neither was reliably present. Even a Dan Wieden-grade agency would probably have struggled against the political sensitivities and diffuse decision structure that characterised the WW marketing function during the rebrand period. The problem was not that MullenLowe lacked the courage to push back. It was that the client-side structure did not provide a reliable place to push back to. The absence of a named decision-maker with clean authority to accept or reject hard creative advice meant that even strong agency challenge would have been absorbed into the same committee dynamics that produced the original incoherence.

The synthesis

The WW case is instructive for the framework because it shows what happens when the Both and relationship collapses in a specific way. The brand tried to be both diet and wellness, both heritage and modernisation, both weight loss and holistic health. These are all legitimate pairings in principle. A brand strategy would embrace the tensions and find a synthesis that honoured each pole without collapsing into one or the other.

But a synthesis requires someone to do the work of synthesising. The Both and does not resolve itself. It requires a named individual or team with the authority, the clarity, and the willingness to make hard decisions about what the synthesis looks like in practice. WW had the tensions but not the synthesis — a state that can be called "Either/And without the resolution," or more simply, incoherence. The result was a brand that signalled different things to different audiences and satisfied none of them.

The The synthesis of WW is not that the tensions were wrong. The original strategic instinct — to modernise a sixty-year-old brand for a new generation while preserving the equity of the existing member base — was defensible. The tensions were real. What was missing was the organisational structure to resolve them. A marketing organisation would have included a clear client-side decision-maker, a disciplined brief that named the tensions and offered a strategic path through them, a feedback structure in which the agency could push back against incoherence, and an intervention right that let the agency refuse work that did not serve the synthesis. WW had none of these, and the brand paid the price in creative incoherence, subscriber decline, financial collapse, and ultimately the departure of its most prominent endorser.

The larger lesson is that synthesis is not rhetorical. It is organisational. A marketing function that names the tensions but does not build the structures to resolve them is not doing evidence-based work. It is doing Either and without the And — holding two positions simultaneously without committing to either, and producing work that reflects the indecision rather than transcending it. WW is a cautionary case about what happens when the organisational scaffolding is missing and even good intentions, serious budgets, and famous endorsements cannot compensate.

Sources

• WW International, Inc. Form 10-K Annual Reports, 2017-2023
• The Wall Street Journal, coverage of the Weight Watchers rebrand and subsequent decline, 2018-2024
• Ad Age, coverage of the WW creative programme, Mindy Grossman's tenure, and the agency relationship, 2018-2022
• Campaign, coverage of the WW rebrand launch and creative evolution, 2018-2022
• CNBC, coverage of WW earnings, strategic shifts, and leadership changes, 2018-2024
• Oprah Winfrey, public statement on departure from the WW board, March 2024
• The New York Times, coverage of the Oprah Winfrey departure and the GLP-1 drug disruption of the weight-loss category, 2023-2024
• Mark Ritson, Marketing Week columns on WW and the wellness rebrand, 2018-2023
• Bloomberg, coverage of WW's debt structure and financial decline, 2020-2024
• Various industry analyses of the GLP-1 drug impact on weight-loss category economics, 2023-2024